After repeated unsuccessful cancer treatments, even the strongest patients can lose hope. But former University of Virginia ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Blood ...

A team of researchers found a potential new target for treating diseases associated with human T-cell leukemia virus type 1, including a specific type of leukemia and a neuroinflammatory disease ...

Imagine a tiny superhero inside every cell of your body whose job is to stop damaged cells before they turn dangerous. That superhero is a gene called TP53, and for decades scientists have known it as ...

Exposure to petrol compounds appears to be associated with an increased risk of childhood leukemia, including acute lymphoblastic leukemia (ALL), according to a systematic review ...

Measurable residual disease-guided ibrutinib-venetoclax therapy achieved undetectable disease in bone marrow in 66.2% of patients with chronic lymphocytic leukemia (CLL) within 2 years compared with ...

Researchers announced a significant paradigm shift in the understanding of T-lineage acute lymphoblastic leukemia (T-ALL), an aggressive and high-risk form of cancer, to one frequently driven by ...

The ASAP trial sets new perspectives on international therapy standards: High-dose chemotherapy is not always necessary before transplantation in cases of acute myeloid leukemia (AML). This means ...

The breakthrough, published Tuesday in the journal Cell, offers a promising new strategy to combat relapse, which occurs in ...

A Falls Church City family’s battle with leukemia and a daughter’s determination to help others facing the disease will be at the center of a community fundraiser this weekend at Dogwood Tavern. From ...